Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The multiple sclerosis self-management scale: clinicometric testing.
Neurological perspectives on voltage-gated sodium channels.
Review of automatic segmentation methods of multiple sclerosis white matter lesions on conventional magnetic resonance imaging.
[Clinical features and prognosis of pediatric multiple sclerosis].
Utilization of physical rehabilitation among people with multiple sclerosis.
Investigating the role of the corpus callosum in regulating motor overflow in multiple sclerosis.
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis.
Pituitary apoplexy presented with optic neuritis.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
[Biomarkers in multiple sclerosis (a review and experimental data)].
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
Injury to white matter tracts in relapsing-remitting multiple sclerosis: A possible therapeutic window within the first 5 years from onset using diffusion-tensor imaging tract-based spatial statistics.
Spiritual wellbeing and perceived uncertainty in patients with multiple sclerosis in south-east Iran.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Autonomic dysfunction in multiple sclerosis.
Sunlight and Vitamin D: Necessary for Public Health.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Neuromyelitis optica spectrum disorder and varicella-zoster infection.
Longitudinal fMRI studies: Exploring brain plasticity and repair in MS.
Neuroinflammatory TNFα Impairs Memory via Astrocyte Signaling.
Patulous eustachian tube after percutaneous balloon microcompression for trigeminal neuralgia: case report.
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
New and Emerging Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: What is New and What is to Come.
Pages
« first
‹ previous
…
455
456
457
458
459
460
461
462
463
…
next ›
last »